journal of managed care & specialty pharmacy | Journament

Journal Ranking

#698 / 33,952
📊 Below Average
Overall Score
41.6/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
35
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 1 week ago

journal of managed care & specialty pharmacy

Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
ncbi ulakbim sci
Short Name j manag care spec pharm
Abbreviated Name j manag care spec pharm
ISSN 2376-1032
Aim and Scope
URL http://www.jmcp.org
Author Instructions

Publications Per Year

Recent Articles (40 total)

2019
Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.
Biskupiak, Joseph;Oderda, Gary;Brixner, Diana;Tang, Derek;Zacker, Christopher;Dalal, Anand A;
Vol. 25 , No. 8 , pp. 859-866
409 views DOI Abstract
2020
Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities.
Serbin, Michael;Devine, Beth;Campbell, Joanna;Basu, Anirban;
Vol. 26 , No. 3 , pp. 325-331
373 views DOI Abstract
2019
Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes.
Hickson, Ryan P;Cole, Ashley L;Dusetzina, Stacie B;
Vol. 25 , No. 1 , pp. 72-79
367 views DOI Abstract
2019
Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population.
Tesell, Mark A;Alper, Caroline J;Bacon, Rachel;Greenwood, Bonnie C;Lenz, Kimberly;Jeffrey, Paul L;Stevens, Karen;
Vol. 25 , No. 9 , pp. 1021-1025
341 views DOI Abstract
2019
The Influence of Allowable Refill Gaps on Detecting Long-Term Opioid Therapy: An Analysis of Population-Based Administrative Dispensing Data Among Patients with Knee Arthritis Awaiting Total Knee Arthroplasty.
Goplen, C Michael;Randall, Jason R;Kang, Sung Hyun;Vakilian, Fatemeh;Jones, C Allyson;Voaklander, Donald C;Beaupre, Lauren A;
Vol. 25 , No. 10 , pp. 1064-1072
340 views DOI Abstract
2020
Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
Hoover, Nathan D;Turner, R Brigg;Sampson, Jaime;Pye, Tiffanie;Hotan, Tanie;
Vol. 26 , No. 1 , pp. 30-34
327 views DOI Abstract
2019
Assessing the Effect of a Telepharmacist's Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures.
Tetuan, Christa;Axon, David Rhys;Bingham, Jennifer;Boesen, Kevin;Lipsy, Robert;Scovis, Nicole;Taylor, Ann M;Warholak, Terri;Lott, Breanne E;Leal, Sandra;
Vol. 25 , No. 12 , pp. 1334-1339
319 views DOI Abstract
2020
Changes in Concurrent Opioid and Benzodiazepine Use Following a Low-Touch Prescriber Fax Intervention.
Yang, Rochelle;Carruth, Sara E;Qiu, Wenyi Amanda;Leslie, R Scott;
Vol. 26 , No. 2 , pp. 160-167
308 views DOI Abstract
2019
Accuracy of Prescription Claims Data in Identifying Truly Nonadherent Patients.
Glassberg, Mrudula B;Trygstad, Troy;Wei, David;Robinson, Tamika;Farley, Joel F;
Vol. 25 , No. 12 , pp. 1349-1356
307 views DOI Abstract
2020
Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts.
Kannarkat, Joseph T;Good, Chester B;Kelly, Erin;Parekh, Natasha;
Vol. 26 , No. 1 , pp. 63-66
299 views DOI Abstract
View All 40 Articles
42
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

41.6/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.0/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

35.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.